|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 337.50 EUR | -1.17% |
|
+1.66% | -5.59% |
| 07-29 | Virbac, without the alibi |  |
| 07-21 | Virbac: Impressive execution in Q2; we smell a guidance upgrade in Q3 |  |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 350 | 384 | 383.5 |
| Spread/Res. | -3.57% | -12.11% | -11.99% |
| Spread/Supp. | +1.66% | +6.47% | +8.87% |
| Support | 332 | 317 | 310 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- VIRP Stock
- Charts Virbac
Select your edition
All financial news and data tailored to specific country editions
